Reuters logo
BRIEF-CytomX reports Q3 loss per share $‍0.28​
November 7, 2017 / 10:12 PM / a month ago

BRIEF-CytomX reports Q3 loss per share $‍0.28​

Nov 7 (Reuters) - CytomX Therapeutics Inc

* CytomX announces third quarter 2017 financial results and operational progress

* Q3 revenue $24.1 million versus $3.5 million

* Q3 revenue view $17.5 million -- Thomson Reuters I/B/E/S

* CytomX Therapeutics Inc qtrly loss per share $‍0.28​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below